Tumor-associated macrophages as a source of functional dendritic cells in ovarian cancer patients
- PMID: 11890716
- DOI: 10.1006/clim.2001.5179
Tumor-associated macrophages as a source of functional dendritic cells in ovarian cancer patients
Abstract
We have generated dendritic cells (DCs) from tumor-associated macrophages (TAMs) obtained from ascites fluid or tumor specimens of ovarian cancer patients, and compared them phenotypically and functionally to DCs derived from the patients' peripheral blood mononuclear cells (PBMCs). Both immature and mature DCs could be generated from TAMs. However, TAM-derived DCs underwent maturation to a lesser degree than PBMC-derived DCs, as measured by DC receptor surface expression. Nonetheless, in allogeneic mixed lymphocyte reactions, TAM-derived DCs stimulated T cell proliferation as efficiently as PBMC-derived DCs. In addition, TAM-derived DCs presenting tumor Ags were capable of stimulating IFN-gamma secretion by tumor-specific T cell lines. Thus, TAMs isolated from ovarian cancer patients can be used to generate significant numbers of DCs. Therefore, TAMs have potential use for either ex vivo or in vivo DC-based immunotherapy, particularly in individuals in which more conventional sources of DCs have been depleted.
Similar articles
-
Biological characteristics of dendritic cells derived from peripheral blood of patients with epithelial ovarian cancer.Ai Zheng. 2009 Feb;28(2):132-7. Epub 2009 Feb 27. Ai Zheng. 2009. PMID: 19550123
-
TRANCE- and CD40 ligand-matured dendritic cells reveal MHC class I-restricted T cells specific for autologous tumor in late-stage ovarian cancer patients.Clin Cancer Res. 2003 Apr;9(4):1517-27. Clin Cancer Res. 2003. PMID: 12684428
-
The functional immaturity of dendritic cells can be relevant to increased tolerance associated with cord blood transplantation.Transfusion. 2007 Feb;47(2):272-9. doi: 10.1111/j.1537-2995.2007.01103.x. Transfusion. 2007. PMID: 17302774
-
IL-6 and leukemia-inhibitory factor are involved in the generation of tumor-associated macrophage: regulation by IFN-γ.Immunotherapy. 2011 Apr;3(4 Suppl):23-6. doi: 10.2217/imt.11.30. Immunotherapy. 2011. PMID: 21524164 Review.
-
Cytokine regulation of monocyte recruitment.Arch Immunol Ther Exp (Warsz). 1995;43(2):149-52. Arch Immunol Ther Exp (Warsz). 1995. PMID: 8744731 Review.
Cited by
-
Bi-specific TCR-anti CD3 redirected T-cell targeting of NY-ESO-1- and LAGE-1-positive tumors.Cancer Immunol Immunother. 2013 Apr;62(4):773-85. doi: 10.1007/s00262-012-1384-4. Epub 2012 Dec 22. Cancer Immunol Immunother. 2013. PMID: 23263452 Free PMC article.
-
Immunologic aspect of ovarian cancer and p53 as tumor antigen.J Transl Med. 2005 Sep 15;3:34. doi: 10.1186/1479-5876-3-34. J Transl Med. 2005. PMID: 16164749 Free PMC article.
-
Rapid tumor vaccine using Toll-like receptor-activated ovarian cancer ascites monocytes.J Immunother Cancer. 2020 Aug;8(2):e000875. doi: 10.1136/jitc-2020-000875. J Immunother Cancer. 2020. PMID: 32817208 Free PMC article.
-
An in vitro investigation into the cytotoxic impact of antigen-presenting dendritic cell-tumor infiltrating lymphocytes on ovarian cancer cells.BMC Cancer. 2024 Nov 7;24(1):1364. doi: 10.1186/s12885-024-13131-7. BMC Cancer. 2024. PMID: 39511530 Free PMC article.
-
Tumor-infiltrating macrophages can predict favorable prognosis in hepatocellular carcinoma after resection.J Cancer Res Clin Oncol. 2009 Mar;135(3):439-49. doi: 10.1007/s00432-008-0469-0. Epub 2008 Sep 10. J Cancer Res Clin Oncol. 2009. PMID: 18781326
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Medical